Rescue, propagation, and partial purification of a helper virus-dependent adenovirus vector
about
The adenovirus genome contributes to the structural stability of the virionAdvances and future challenges in recombinant adenoviral vectored H5N1 influenza vaccinesAn adenovirus type 5 (Ad5) amplicon-based packaging cell line for production of high-capacity helper-independent deltaE1-E2-E3-E4 Ad5 vectors.Gutless adenovirus: last-generation adenovirus for gene therapyVirus-mediated gene transfer to induce therapeutic angiogenesis: where do we stand?Comparison of replication-competent, first generation, and helper-dependent adenoviral vaccinesGeneration of cell lines to complement adenovirus vectors using recombination-mediated cassette exchange.Generation of an adenovirus vector lacking E1, e2a, E3, and all of E4 except open reading frame 3.Effects of stuffer DNA on transgene expression from helper-dependent adenovirus vectors."Stealth" adenoviruses blunt cell-mediated and humoral immune responses against the virus and allow for significant gene expression upon readministration in the lungLifetime correction of genetic deficiency in mice with a single injection of helper-dependent adenoviral vectorA novel system for the production of fully deleted adenovirus vectors that does not require helper adenovirus.Nonneurotropic adenovirus: a vector for gene transfer to the brain and gene therapy of neurological disordersImprovements in adenoviral vector technology: overcoming barriers for gene therapy.Gene therapy in wound repair and regeneration.Modelling Fanconi anemia pathogenesis and therapeutics using integration-free patient-derived iPSCsOptimization of the helper-dependent adenovirus system for production and potency in vivo.Site-specific integration mediated by a hybrid adenovirus/adeno-associated virus vector.Implications of the innate immune response to adenovirus and adenoviral vectors.Long-term doxycycline-controlled expression of human tyrosine hydroxylase after direct adenovirus-mediated gene transfer to a rat model of Parkinson's disease.Efficient and accurate homologous recombination in hESCs and hiPSCs using helper-dependent adenoviral vectors.Gene therapy for cystic fibrosis: challenges and future directionsRecombinant adenoviruses with large deletions generated by Cre-mediated excision exhibit different biological properties compared with first-generation vectors in vitro and in vivo.A helper-dependent system for adenovirus vector production helps define a lower limit for efficient DNA packaging.A helper-dependent adenovirus vector system: removal of helper virus by Cre-mediated excision of the viral packaging signal.An adenoviral vector deleted for all viral coding sequences results in enhanced safety and extended expression of a leptin transgene.Adenoviral vectors: development and application.Helper-dependent adenoviral vectors in experimental gene therapy.Cellular immune response to adenoviral vector infected cells does not require de novo viral gene expression: implications for gene therapy.Gene therapy for pituitary tumors.Gene transfer strategies in tissue engineeringE1A and E1B proteins inhibit inflammation induced by adenovirus.Highly efficient transient gene expression and gene targeting in primate embryonic stem cells with helper-dependent adenoviral vectors.Characterization of a replication-incompetent adenovirus type 5 mutant deleted for the preterminal protein gene.Prospects, promise and problems on the road to effective vaccines and related therapies for substance abuseInterception of cocaine by enzyme or antibody delivered with viral gene transfer: a novel strategy for preventing relapse in recovering drug users.Established immunity precludes adenovirus-mediated gene transfer in rat carotid arteries. Potential for immunosuppression and vector engineering to overcome barriers of immunity.Switching a replication-defective adenoviral vector into a replication-competent, oncolytic adenovirus.A new adenoviral vector: Replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and beta-galactosidase.Advances and future challenges in adenoviral vector pharmacology and targeting.
P2860
Q26825101-91F69F1F-3FE6-4A67-8204-AFA26FD2A7B8Q27013568-8EDDA441-2069-4458-B490-A4234C314BDFQ27469506-7892B7D4-A8A6-4A42-BAC8-D0052CC09E87Q28277560-D4778488-9A16-4C50-86D8-3C5EEBC26EB7Q30489689-7F022181-A89F-4E30-AEDE-A8AF3DE6FD7CQ33424498-B7530174-4BC8-45BE-A605-FFC9C1F30237Q33779555-C7E4FA9C-8113-4789-B1CE-6EDC682714EEQ33815920-2D980805-1DD4-4517-91A6-CAE75CEC4DE9Q33818929-A869B164-A16A-4F10-B68C-B3B4F2D0B212Q33841039-529BB8C4-7F61-4193-AC2C-90A6308E7AB2Q33949311-C4212D84-555D-4C49-9FDE-08F391917F1EQ33952908-6DC8F46A-CA6A-4049-8E04-BE25E9612564Q33985663-826C552B-FA74-474B-A4F9-AAEB0A6496CBQ34005922-2CB8EB70-D400-4484-B484-1EFD430FE3E2Q34156741-F2B52B93-54FD-4A53-B5C3-36C2C89F1362Q34918292-EC2B325D-603F-4502-993A-712BCFB4B78DQ34996749-A29507CE-1C5A-40C4-8D6A-B3CE7C6E0207Q35057135-EDF4A2A9-DB92-461F-9F3B-4B2A0C7C3216Q35085363-75181C03-020B-41F8-ACB2-84DA027578ADQ35734505-DF2F8640-A518-4896-9845-8F3AE57ACA59Q35749996-EA2C19CB-45A9-4796-9FBE-3214A128CB80Q35767578-7C563C8D-040A-4675-9EF6-04E52E6B51E7Q35874197-CE025D59-E81C-4C4C-B0B6-5FD1ADFBFEDEQ35881805-532CFDC6-3A65-4CAF-9FEE-AB00220ABEA9Q35915922-F0BDA9DB-F83E-4EDF-84D9-7E473CDF1F7FQ36163092-485E8CCE-96EB-4346-9C6A-58A9A9A40A70Q36179657-38E1AB7F-D6B6-4F55-AC59-070E024B5F17Q36219334-5A8223C9-4505-4D42-A976-F6B739A69EE2Q36310768-D821EF52-5AFE-4E5C-B137-BCEE27162676Q36386450-9D8929DE-21CB-452B-B1D3-5D3CAE22389BQ36815336-AD5B1721-71CB-4C6F-BFDF-F74CBD752B13Q36854089-1C3210AA-3806-4DE9-AB34-A06CC51176D4Q36893512-93662CDD-A83A-412A-8EF1-542F02C240E1Q37048872-F9663A82-09D8-4DD7-B3EE-F81AF1AA7F6FQ37082158-4C8639BB-1118-474E-BED7-47F0A734F9A6Q37082190-3B4D421A-0FF0-4ABB-AAB0-BE303AF0AFCDQ37362429-4FA93F66-9B10-4D57-BC19-1237163541FCQ37547783-C1C06A9A-82FA-441D-BE9C-AEBC4E627656Q37551841-D68C20C9-BE3A-4BA4-881C-50BB7D1C0075Q37859842-2E461032-9A5F-4082-B234-0212F55B27CB
P2860
Rescue, propagation, and partial purification of a helper virus-dependent adenovirus vector
description
1995 nî lūn-bûn
@nan
1995 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Rescue, propagation, and parti ...... us-dependent adenovirus vector
@ast
Rescue, propagation, and parti ...... us-dependent adenovirus vector
@en
Rescue, propagation, and parti ...... us-dependent adenovirus vector
@nl
type
label
Rescue, propagation, and parti ...... us-dependent adenovirus vector
@ast
Rescue, propagation, and parti ...... us-dependent adenovirus vector
@en
Rescue, propagation, and parti ...... us-dependent adenovirus vector
@nl
prefLabel
Rescue, propagation, and parti ...... us-dependent adenovirus vector
@ast
Rescue, propagation, and parti ...... us-dependent adenovirus vector
@en
Rescue, propagation, and parti ...... us-dependent adenovirus vector
@nl
P2093
P2860
P356
P1476
Rescue, propagation, and parti ...... us-dependent adenovirus vector
@en
P2093
P2860
P304
P356
10.1073/PNAS.92.9.3854
P407
P577
1995-04-01T00:00:00Z